Follow
Bryan C Fuchs
Bryan C Fuchs
Assistant Professor of Surgery, Harvard Medical School
Verified email at mgh.harvard.edu
Title
Cited by
Cited by
Year
Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?
BC Fuchs, BP Bode
Seminars in cancer biology 15 (4), 254-266, 2005
7682005
Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells
BC Fuchs, T Fujii, JD Dorfman, JM Goodwin, AX Zhu, M Lanuti, ...
Cancer research 68 (7), 2391-2399, 2008
3962008
Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells
BC Fuchs, T Fujii, JD Dorfman, JM Goodwin, AX Zhu, M Lanuti, ...
Cancer research 68 (7), 2391-2399, 2008
3962008
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
BC Fuchs, Y Hoshida, T Fujii, L Wei, S Yamada, GY Lauwers, CM McGinn, ...
Hepatology 59 (4), 1577-1590, 2014
3442014
Inhibition of acetyl-CoA carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma
JSV Lally, S Ghoshal, DK DePeralta, O Moaven, L Wei, R Masia, ...
Cell metabolism 29 (1), 174-182. e5, 2019
2622019
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis
KK Tanabe, A Lemoine, DM Finkelstein, H Kawasaki, T Fujii, RT Chung, ...
Jama 299 (1), 53-60, 2008
2542008
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
Y Hoshida, BC Fuchs, N Bardeesy, TF Baumert, RT Chung
Journal of hepatology 61 (1), S79-S90, 2014
2422014
Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor
T Fujii, BC Fuchs, S Yamada, GY Lauwers, Y Kulu, JM Goodwin, M Lanuti, ...
BMC gastroenterology 10, 1-11, 2010
2282010
HCV-induced epigenetic changes associated with liver cancer risk persist after sustained virologic response
N Hamdane, F Jühling, E Crouchet, H El Saghire, C Thumann, MA Oudot, ...
Gastroenterology 156 (8), 2313-2329. e7, 2019
2122019
Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition
S Nakagawa, L Wei, WM Song, T Higashi, S Ghoshal, RS Kim, CB Bian, ...
Cancer cell 30 (6), 879-890, 2016
1842016
A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma
BKA Dayyeh, M Yang, BC Fuchs, DL Karl, S Yamada, JJ Sninsky, ...
Gastroenterology 141 (1), 141-149, 2011
1702011
ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells
BC Fuchs, RE Finger, MC Onan, BP Bode
American Journal of Physiology-Cell Physiology 293 (1), C55-C63, 2007
1542007
Stressing out over survival: glutamine as an apoptotic modulator
BC Fuchs, BP Bode
Journal of Surgical Research 131 (1), 26-40, 2006
1532006
Molecular MRI of collagen to diagnose and stage liver fibrosis
BC Fuchs, H Wang, Y Yang, L Wei, M Polasek, DT Schühle, GY Lauwers, ...
Journal of hepatology 59 (5), 992-998, 2013
1502013
Cost-effectiveness of risk score–stratified hepatocellular carcinoma screening in patients with cirrhosis
N Goossens, AG Singal, LY King, KL Andersson, BC Fuchs, C Besa, ...
Clinical and translational gastroenterology 8 (6), e101, 2017
1472017
Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer
S Yamada, BC Fuchs, T Fujii, Y Shimoyama, H Sugimoto, S Nomoto, ...
Surgery 154 (5), 946-954, 2013
1392013
Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells
BP Bode, BC Fuchs, BP Hurley, JL Conroy, JE Suetterlin, KK Tanabe, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 283 (5 …, 2002
1342002
Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation
J Bates, A Vijayakumar, S Ghoshal, B Marchand, S Yi, D Kornyeyev, ...
Journal of hepatology 73 (4), 896-905, 2020
1322020
Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cells
BC Fuchs, JC Perez, JE Suetterlin, SB Chaudhry, BP Bode
American Journal of Physiology-Gastrointestinal and Liver Physiology 286 (3 …, 2004
1232004
Type I collagen–targeted PET probe for pulmonary fibrosis detection and staging in preclinical models
P Désogère, LF Tapias, LP Hariri, NJ Rotile, TA Rietz, CK Probst, F Blasi, ...
Science translational medicine 9 (384), eaaf4696, 2017
1202017
The system can't perform the operation now. Try again later.
Articles 1–20